Stock Report

Indo US Bio-Tech Ltd posts H1FY21 PAT of Rs. 1.48 crore



Posted On : 2020-11-13 12:33:33( TIMEZONE : IST )

Indo US Bio-Tech Ltd posts H1FY21 PAT of Rs. 1.48 crore

Indo Us Bio-Tech Ltd has reported financial results for the period ended September 30, 2020.

Financial Results (H1 FY20-21)

The company has reported net sales of Rs.16.87 crores during the 6 months period ended September 30, 2020 as compared to Rs.21.74 crores during the period ended March 31, 2020.

The company has posted net profit of Rs.1.48 crores for the 6 months period ended September 30, 2020 as against Rs.1.32 crores for the 6 months period ended March 31, 2020.

The company has reported EPS of Rs.2.44 for the 6 months period ended September 30, 2020 as compared to Rs.2.18 for the 6 months period ended March 31, 2020.

FinancialsH1 FY20-21H2 FY19-20% Change
Total Income₹ 16.87 crs₹ 21.74 crsUp Tick -22.4%
Net Profit₹ 1.48 crs₹ 1.32 crsUp Tick 12.12%
EPS₹ 2.44₹ 2.18Up Tick 11.93%

Financial Results (H1 FY20-21) - YoY Comparison

The company has reported net sales of Rs.16.87 crores during the 6 months period ended September 30, 2020 as compared to Rs.18.02 crores during the 6 months period ended September 30, 2019.

The company has posted net profit of Rs.1.48 crores for the 6 months period ended September 30, 2020 as against Rs.1.21 crores for the 6 months period ended September 30, 2019.

The company has reported EPS of Rs.2.44 for the 6 months period ended September 30, 2020 as compared to Rs.2 for the 6 months period ended September 30, 2019.

FinancialsH1 FY20-21H1 FY19-20% Change
Total Income₹ 16.87 crs₹ 18.02 crsUp Tick -6.38%
Net Profit₹ 1.48 crs₹ 1.21 crsUp Tick 22.31%
EPS₹ 2.44₹ 2Up Tick 22%

Source : Equity Bulls

Keywords